Robeauté, lauréat de l'édition 2024
Robeauté wins the Prix de l'Innovation des dispositifs médicaux et des nouvelles technologies en santé at the 12th edition.
Robeauté is developing a modular neurosurgical micro-robotic medical device that enables transparent intervention in the brain's extracellular matrix.
From the biopsy of brain tumors, impossible in certain areas of the brain, to the reasoned choice of therapeutic strategies and the ultra-targeted delivery of adapted therapies, Robeauté's cutting-edge technology and its micro-robot (the size of a grain of rice), offer a revolutionary prospect for people suffering from brain tumors and, in the longer term, neurological diseases (stroke, Parkinson's and Alzheimer's).
"We hope to make our technology available to healthcare professionals and patients within the next four years," said Quentin François, Product Manager at Robeauté, at the awards ceremony.
Electroducer was a finalist in this 2024 edition for its electro-conductive medical device, in the field of interventional cardiology (prize awarded to Sébastien Weisbuch, Medicalps CEO).
Translated with
Awards presented in the presence of Catherine Staron, Vice President for Higher Education, Research and Innovation, and the members of the 2024 Innovation Contest jury (from left to right): Léa Pierre-Joseph (Décideurs magazine), Olivier Chabanon (France Biotech), Maude Boulanger (CIC), Anne Le Bars (Service Économique de l'État en Région), Matthieu Ribon (Biomérieux).
For any use of photos from the 2024 edition, please credit: © Momento - Médi'Nov Connection 2024